# Gulf Resources, Inc.: overview GURE · Nasdaq · CIK 885462 · [Materials](/sectors/materials.md) · fiscal year ends Dec 31 Pages: [Overview](/companies/gure.md) · [Financials](/companies/gure/financials.md) · [Filings](/companies/gure/filings.md) · [Insiders](/companies/gure/insiders.md) Latest reported revenue: [$12.9m](/filings/0001493152-26-045127.md) for Q2 FY2026, three months to 2026-06-30, from the 10-Q filed Sep 30, 2026 (XBRL us-gaap:Revenues, accession 0001493152-26-045127). ## Last eight quarters | Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [2.2](/filings/0001193805-25-001627.md) | [1.7 d](/filings/0001493152-26-044873.md) | [1.6](/filings/0001493152-26-045126.md) | [8.3](/filings/0001493152-26-045127.md) | [9.0](/filings/0001193805-25-001627.md) | [6.4 d](/filings/0001493152-26-044873.md) | [2.4](/filings/0001493152-26-045126.md) | [12.9](/filings/0001493152-26-045127.md) | | Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Operating margin | % | [(204.3%)](/filings/0001193805-25-001627.md) | [(419.5%) d](/filings/0001493152-26-044873.md) | [(289.9%)](/filings/0001493152-26-045126.md) | [(9.5%)](/filings/0001493152-26-045127.md) | [(3.7%)](/filings/0001193805-25-001627.md) | [(44.7%) d](/filings/0001493152-26-044873.md) | [(171.3%)](/filings/0001493152-26-045126.md) | [9.7%](/filings/0001493152-26-045127.md) | | Net margin | % | [(155.8%)](/filings/0001193805-25-001627.md) | [(1117.6%) d](/filings/0001493152-26-044873.md) | [(291.1%)](/filings/0001493152-26-045126.md) | [(9.8%)](/filings/0001493152-26-045127.md) | [(394.3%)](/filings/0001193805-25-001627.md) | [(44.4%) d](/filings/0001493152-26-044873.md) | [(165.8%)](/filings/0001493152-26-045126.md) | [8.9%](/filings/0001493152-26-045127.md) | | Diluted EPS | $ per share | not reported | not reported | [(3.93)](/filings/0001493152-26-045126.md) | [(0.60)](/filings/0001493152-26-045127.md) | not reported | not reported | [(2.48)](/filings/0001493152-26-045126.md) | [0.64](/filings/0001493152-26-045127.md) | | Free cash flow | $m | [(31.1) d](/filings/0001193805-25-001627.md) | [(30.6) d](/filings/0001493152-26-044873.md) | not reported | not reported | not reported | [3.1 d](/filings/0001493152-26-044873.md) | [0.6](/filings/0001493152-26-045126.md) | [(6.5) d](/filings/0001493152-26-045127.md) | - Revenue. XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure. - Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure. ## Last five fiscal years | Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) | | --- | --- | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [55.0](/filings/0001193805-23-000424.md) | [66.1](/filings/0001193805-24-001184.md) | [30.0](/filings/0001193805-26-001126.md) | [7.7](/filings/0001493152-26-044873.md) | [25.4](/filings/0001493152-26-044873.md) | | Gross margin | % | not reported | not reported | not reported | not reported | not reported | | Operating margin | % | [9.5%](/filings/0001193805-23-000424.md) | [24.9%](/filings/0001193805-24-001184.md) | [(39.6%)](/filings/0001193805-26-001126.md) | [(290.4%)](/filings/0001493152-26-044873.md) | [(33.7%)](/filings/0001493152-26-044873.md) | | Net margin | % | [(1.7%)](/filings/0001193805-23-000424.md) | [15.2%](/filings/0001193805-24-001184.md) | [(205.7%)](/filings/0001193805-26-001126.md) | [(781.9%)](/filings/0001493152-26-044873.md) | [(172.8%)](/filings/0001493152-26-044873.md) | | Diluted EPS | $ per share | [(0.09)](/filings/0001193805-22-000613.md) | not reported | [(58.16)](/filings/0001193805-26-001126.md) | [(54.88)](/filings/0001493152-26-044873.md) | [(32.95)](/filings/0001493152-26-044873.md) | | Free cash flow | $m | [(6.8)](/filings/0001193805-23-000424.md) | [13.6](/filings/0001193805-24-001184.md) | not reported | [(28.2)](/filings/0001493152-26-044873.md) | [(1.0)](/filings/0001493152-26-044873.md) | - Revenue. XBRL Revenue: us-gaap:Revenues. - Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:Revenues. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:Revenues. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareBasicAndDiluted; Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing. ## Insider purchases and sales The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/gure/insiders.md) None in coverage. ## Funds that report holding it From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md) | Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before | | --- | --- | ---: | ---: | --- | --- | | [CITADEL ADVISORS LLC](/funds/1423053.md) | 2026-06-30 | $118.8k | 32,538 | | Added +10,491 | | [TWO SIGMA INVESTMENTS, LP](/funds/1179392.md) | 2026-06-30 | $53.5k | 14,652 | | Reduced −2,931 | | [LANARK FINANCIAL, INC.](/funds/791540.md) | 2026-06-30 | $164 | 45 | | Unchanged | | [INTERNATIONAL ASSETS INVESTMENT MANAGEMENT, LLC](/funds/1818604.md) | 2026-06-30 | $36 | 10 | | Unchanged | | [Caitong International Asset Management Co., Ltd](/funds/1963355.md) | 2026-06-30 | $11 | 3 | | New +3 | | [SBI Securities Co., Ltd.](/funds/1851815.md) | 2026-06-30 | $4 | 1 | | New +1 | | [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $4 | 1 | | Unchanged | | [OSAIC HOLDINGS, INC.](/funds/1677044.md) | 2026-06-30 | $3 | 1 | | Unchanged | ## Recent filings [All 595 filings](/companies/gure/filings.md) | Filed | Accepted | Form | What it is | Accession | | --- | --- | --- | --- | --- | | 2026-10-15 | 15:44 ET | [8-K](/filings/0001493152-26-047183.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-047183 | | 2026-10-06 | 12:45 ET | [8-K](/filings/0001493152-26-045874.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-045874 | | 2026-10-02 | 10:03 ET | [DEF 14A](/filings/0001493152-26-045416.md) | Proxy statement, period 2026-10-02 | 0001493152-26-045416 | | 2026-09-30 | 20:51 ET | [10-Q](/filings/0001493152-26-045127.md) | Quarterly report, period 2026-06-30 | 0001493152-26-045127 | | 2026-09-30 | 20:49 ET | [10-Q/A](/filings/0001493152-26-045126.md) | Quarterly report, amended, period 2026-03-31 | 0001493152-26-045126 | | 2026-09-30 | 20:47 ET | [10-Q/A](/filings/0001493152-26-045125.md) | Quarterly report, amended, period 2025-06-30 | 0001493152-26-045125 | | 2026-09-30 | 20:45 ET | [10-Q/A](/filings/0001493152-26-045124.md) | Quarterly report, amended, period 2025-03-31 | 0001493152-26-045124 | | 2026-09-29 | 20:30 ET | [10-K/A](/filings/0001493152-26-044873.md) | Annual report, amended, period 2025-12-31 | 0001493152-26-044873 | | 2026-09-03 | 20:30 ET | [8-K](/filings/0001193805-26-001185.md) | 3.01 Delisting notice | 0001193805-26-001185 | | 2026-08-28 | 20:45 ET | [10-Q](/filings/0001193805-26-001157.md) | Quarterly report, period 2026-03-31 | 0001193805-26-001157 | ## Latest annual report [Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001193805-26-001105.md), filed Aug 17, 2026. ## Forecast league Q3 FY2026, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by \[object Promise\]. [Forecast this quarter](/leagues/2026q3/targets/0fc5e138-53d1-423c-ae94-1f11b4cc7087) ## About the filer - CIK: 885462 - Tickers: GURE - Exchange: Nasdaq - SIC code: 2800 Chemicals & Allied Products - State of incorporation: NV - Filer category: Non-accelerated filer
Smaller reporting company Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:27 ET. No prices; not investment advice.